Share Facebook Twitter LinkedIn WhatsApp Pinterest Email Amy Burroughs, Terns Pharma CEO, joins ‘Closing Bell Overtime’ to talk progress in its GLP-1 drug development.
Bloomberg This Weekend | New Strikes on Iran, Devastation in Venezuela, AI Election InfluenceJune 27, 2026